It is going to look a little bizarre, but there is a great reason behind the change… Nike have changed their logo on third kits to celebrate women's football. They explained their switch for ...

The best logo maker helps you craft the right branding for your business - even if you've never designed a logo before. Our team of expert reviewers have tested the best free logo makers and the ...

The best free logo maker lets you create eye-catching graphics to market your business completely free. Our team of creatives tested out the best logo makers and the best graphic design software ...

A Reddit thread started Thursday titled, "What's wrong with the Facebook logo?" shows a blue lowercase "f" on a black background instead of a blue background with a white "f." Some users who have ...

The phase I/II MAMMOTH (ZN-c3-006) study is evaluating azenosertib in combination with GSK’s GSK PARP inhibitor Zejula (niraparib) and azenosertib as monotherapy for treating PROC. The study is ...

Founded by former Tesaro founder Leon Moulder, Zenas was incorporated in 2019. Tesaro, which developed the PARP inhibitor Zejula, was acquired by GSK in 2018 for $5.1 billion. Neither Zenas nor Bicara ...

What do Apple, Amazon, Baskin Robbins, and Toblerone have in common? They have hidden messages in their logos—here's what they are and what they mean. As consumers, we see company logos daily.

Women with newly-diagnosed advanced ovarian cancer have a new treatment option in England after NICE recommend interim funding for GlaxoSmithKline’s Zejula (niraparib) in final guidance.

AstraZeneca’s ovarian cancer drug Lynparza is facing competition in Europe with Tesaro's rival Zejula now set for launch. Zejula (niraparib) has now gained final marketing approval from the the ...